The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 30, 2019

Filed:

Mar. 15, 2013
Applicants:

Children's Medical Center Corporation, Boston, MA (US);

The General Hospital Corporation, Boston, MA (US);

Inventors:

Leonard I. Zon, Wellesley, MA (US);

Trista E. North, Newton Center, MA (US);

Wolfram Goessling, Chestnut Hill, MA (US);

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/14 (2015.01); C12N 5/0789 (2010.01); A61K 35/28 (2015.01); A61K 45/06 (2006.01); A61K 31/575 (2006.01); A61K 35/50 (2015.01); A61P 43/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/14 (2013.01); A61K 31/575 (2013.01); A61K 35/28 (2013.01); A61K 35/50 (2013.01); A61K 45/06 (2013.01); A61P 43/00 (2018.01); C12N 5/0647 (2013.01); C12N 2501/02 (2013.01);
Abstract

The present invention provides for compositions and methods for modulating hematopoetic stem cell populations by using HCS modulators, which are agents that either increase HSC numbers or decrease HSC numbers as desired by a particular indication. For example, HSC modulators found to increase HSC numbers include prostaglandin E(PGE2) and agents that stimulate the PGE2 pathway. Conversely, HSC modulators that prevent PGE2 synthesis decrease HSC numbers. HCS modulators may be used in vitro, in vivo, or ex vivo.


Find Patent Forward Citations

Loading…